Aspira Women's Health Inc. (AWHL)
OTCMKTS
· Delayed Price · Currency is USD
0.0265
-0.0035 (-11.67%)
At close: Apr 23, 2025
Aspira Women's Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 9.18 | 9.15 | 8.18 | 6.81 | 4.65 | Upgrade
|
| Revenue Growth (YoY) | 0.31% | 11.85% | 20.14% | 46.46% | 2.49% | Upgrade
|
| Cost of Revenue | 3.7 | 3.89 | 3.86 | 3.75 | 3.17 | Upgrade
|
| Gross Profit | 5.48 | 5.26 | 4.32 | 3.06 | 1.49 | Upgrade
|
| Selling, General & Admin | 18.54 | 20.16 | 29.59 | 30.42 | 17.17 | Upgrade
|
| Research & Development | 3.21 | 3.96 | 5.87 | 5.24 | 2.05 | Upgrade
|
| Operating Expenses | 21.76 | 24.11 | 35.46 | 35.66 | 19.22 | Upgrade
|
| Operating Income | -16.28 | -18.85 | -31.14 | -32.6 | -17.73 | Upgrade
|
| Interest Expense | -0.03 | - | - | -0.05 | - | Upgrade
|
| Interest & Investment Income | - | 0.05 | 0.02 | - | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.22 | 0.52 | 1.24 | -0.03 | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | -15.09 | -18.29 | -29.89 | -32.67 | -17.66 | Upgrade
|
| Other Unusual Items | 2 | 1.6 | - | 1.01 | -0.25 | Upgrade
|
| Pretax Income | -13.09 | -16.69 | -29.89 | -31.66 | -17.91 | Upgrade
|
| Net Income | -13.09 | -16.69 | -29.89 | -31.66 | -17.91 | Upgrade
|
| Net Income to Common | -13.09 | -16.69 | -29.89 | -31.66 | -17.91 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 9 | 8 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 9 | 8 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | 53.08% | 18.85% | 4.79% | 10.41% | 16.31% | Upgrade
|
| EPS (Basic) | -0.93 | -1.81 | -3.85 | -4.27 | -2.67 | Upgrade
|
| EPS (Diluted) | -0.93 | -1.81 | -3.85 | -4.27 | -2.70 | Upgrade
|
| Free Cash Flow | -12.15 | -15.92 | -31.3 | -27.58 | -15.22 | Upgrade
|
| Free Cash Flow Per Share | -0.86 | -1.72 | -4.03 | -3.72 | -2.27 | Upgrade
|
| Gross Margin | 59.67% | 57.48% | 52.82% | 44.95% | 31.95% | Upgrade
|
| Operating Margin | -177.28% | -205.94% | -380.47% | -478.49% | -381.23% | Upgrade
|
| Profit Margin | -142.61% | -182.33% | -365.16% | -464.80% | -384.97% | Upgrade
|
| Free Cash Flow Margin | -132.32% | -173.89% | -382.45% | -404.86% | -327.33% | Upgrade
|
| EBITDA | -16.19 | -18.65 | -30.87 | -32.29 | -17.47 | Upgrade
|
| EBITDA Margin | -176.28% | -203.77% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.09 | 0.2 | 0.26 | 0.3 | 0.27 | Upgrade
|
| EBIT | -16.28 | -18.85 | -31.14 | -32.6 | -17.73 | Upgrade
|
| EBIT Margin | -177.28% | -205.94% | - | - | - | Upgrade
|
| Revenue as Reported | 9.18 | 9.15 | 8.18 | 6.81 | 4.65 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.